JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A1805 Imatinib Mesylate (STI571)
2 Citation

Target: PDGFR|c-Kit|Bcr-Abl

Summary: Abl/c-kit/PDGFR inhibitor

≥29.5 mg/mL
A1723 Roscovitine (Seliciclib,CYC202)
2 Citation

Summary: CDK inhibitor,potent and selective

insoluble in H2O; ≥17.72 mg/mL
A2213 17-DMAG (Alvespimycin) HCl
1 Citation

Target: HSP90

Summary: Hsp90 inhibitor

≥26.2 mg/mL
A1266 WYE-354

Summary: MTOR inhibitor,potent,ATP-competitive and cell-permeable

≥49.6 mg/mL
A1748 Ramelteon
1 Citation

Target: Melatonin Receptors

Summary: Agonist of melatonin receptor(M1-M2),highly selective

insoluble in H2O; ≥12.95 mg/mL
A2986 ADL5859 HCl

Summary: δ-opioid receptor agonist,selective

≥21.45 mg/mL
A1404 Rigosertib sodium salt
1 Citation

Target: PLK

Summary: Plk1 inhibitor

≥23.65 mg/mL
A1186 AMG-208

Summary: C-Met inhibitor,potent and highly selective

insoluble in EtOH; insoluble in H2O; ≥3.83 mg/mL
A2806 BX-912

Summary: PDK1 inhibitor,potent and ATP-competitive

≥23.55 mg/mL
A1718 Posaconazole

Target: Cytochrome P450 (CYP450)|sterol demethylase

Summary: Sterol C14ɑ demethylase inhibitor

≥35.04 mg/mL